Despite the consensus regarding the role of BCR signaling in the biology of CLL, the response of CLL cells to BCR stimulation in vitro is notoriously heterogeneous among patient samples (43). The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.